You are here

An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Beth Israel Hosp
Boston, Massachusetts, 02215 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Mycobacterium Avium-Intracellulare Infection, HIV Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Concurrent Medication:

Allowed:

- Medications allowed under a Treatment IND program.

Patients must have:

- HIV infection.

- Disseminated Mycobacterium avium Complex.

- Fever (> 100 degrees F) that cannot be attributed to another active infection, and at
least one other constitutional symptom (such as fatigue, malaise, anorexia).

- Life expectancy of at least the duration of the study.

- Consent of parent or guardian if below the legal age of consent.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Co-existing Condition:

Patients with the following symptoms and conditions are excluded:

- Known hypersensitivity or significant intolerance to macrolide antibiotics.

- Inability to take oral medications or a current condition likely to interfere with
drug absorption (e.g., gastrectomy).

Prior Medication:

Excluded:

- Treatment with an immunostimulant or immunomodulator compound such as
alpha-interferon, gamma-interferon, or any interleukin within 7 days prior to study
entry.

- Any other antibiotic with known activity against M. avium within 7 days prior to study
entry.

Not expected to comply with the requirements of the protocol, in the opinion of the
investigator.

NCT00002090
Pfizer
Completed
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Mycoses, HIV Infections
NCT00002277
All Genders
13+
Years
Multiple Sites
Mycobacterium Avium-Intracellulare Infection, HIV Infections
NCT00002309
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now